# Tailored molecular weight hyaluronic acid production by engineered Lactococcus lactis

**Authors:** Sharath Soundiraraj, Nakul Ravishankar, Pandeeswari Jeeva, Lars M. Blank, Guhan Jayaraman

PMC · DOI: 10.1186/s12934-026-02945-8 · Microbial Cell Factories · 2026-02-24

## TL;DR

Scientists engineered bacteria to produce hyaluronic acid of specific molecular weights, eliminating the need for post-processing.

## Contribution

A combinatorial strategy using multiple variables to directly synthesize hyaluronic acid at desired molecular weights in Lactococcus lactis.

## Key findings

- HA synthases from S. uberis and S. parauberis produce higher molecular weight HA compared to S. pyogenes.
- Deleting the ldh gene and co-expressing hasE increases HA molecular weight by improving precursor availability.
- Tailored HA with molecular weights from 0.2 to 2.6 MDa was achieved through multiplexed strain engineering.

## Abstract

Hyaluronic acid (HA) is a glycosaminoglycan with a wide range of biological functions that depend on its molecular weight (MW). Recently, there has been an increasing interest in producing HA at particular MWs for various cosmetic and biomedical applications. HA is traditionally produced by extraction or microbial fermentation, which is then subjected to chemical or enzymatic treatments to customize the MW. On the other hand, direct microbial synthesis at desired MWs has considerable advantages over conventional techniques. The present study introduces a combinatorial approach using four critical variables which influence the molecular weight of HA (MWHA): (1) Expression of HA synthases from different Streptococcus species (S. parauberis, S. uberis, S. zooepidemicus, and S. pyogenes) which intrinsically produce different MWHA; (2) Supply of HA precursors by varying heterlogous gene expression in the HA-precursor pathways (hasAB vs. hasABE); (3) Re-routing of metabolic fluxes by deletion of the lactate dehydrogenase (ldh) gene; and (4) Varying the initial glucose concentration in batch fermentation.

Recombinant Lactococcus lactis strains expressing HA synthase genes taken from diverse Streptococcal sp. were found to produce varying MWHA under otherwise identical genetic and bioreactor conditions. The HA synthases sourced from S. uberis and S. parauberis synthesized higher MWHA, whereas those from S. pyogenes produced lower MWHA. In silico analysis of the HA synthase sequences indicated that differences in the transmembrane regions among the various isoforms are the probable cause of variations in MWHA. Compared to their wild-type counterparts, ldh-knockout L. lactis strains showed a noticeable increase in MWHA due to a substantial increase in HA precursor levels. Further, the co-expression of hasE in addition to hasAB, considerably increased MWHA due to a better balance of the intracellular HA-precursor ratios. This multiplexing approach, involving simultaneous manipulation of the above factors, allowed us to produce HA with tailored MWHA over a broad range from 0.2 to 2.6 MDa.

Our technology eliminates the need for enzymatic desizing or post-processing of HA to achieve the desired MWHA. In summary, this multiplexing approach enables one-pot synthesis of desired MWHA, opening up new avenues for producing customized HA.

The online version contains supplementary material available at 10.1186/s12934-026-02945-8.

## Linked entities

- **Genes:** hasE (metalloprotease secretion protein) [NCBI Gene 880019], Ldh (Lactate dehydrogenase) [NCBI Gene 45880]
- **Species:** Lactococcus lactis (taxon 1358), Streptococcus parauberis (taxon 1348), Streptococcus uberis (taxon 1349), Streptococcus pyogenes (taxon 1314)

## Full-text entities

- **Diseases:** HA (MESH:D011015), osteoarthritis (MESH:D010003), inflammation (MESH:D007249), pain (MESH:D010146), cancer (MESH:D009369), cytotoxic (MESH:D064420), MWHA (MESH:C567116)
- **Chemicals:** NaNO3 (MESH:C031618), glutamine (MESH:D005973), Acetyl-CoA (MESH:D000105), isopropanol (MESH:D019840), SDS (MESH:D012967), ascorbic acid (MESH:D001205), NAD + (MESH:D009243), acetate (MESH:D000085), HA (MESH:D006820), UDP-sugar (MESH:D014539), PGA (MESH:C511775), erythromycin (MESH:D004917), chloramphenicol (MESH:D002701), ethanol (MESH:D000431), Glucose (MESH:D005947), NaCl (MESH:D012965), UDP-N-acetylglucosamine (MESH:D014537), methanol (MESH:D000432), UDP glucuronic acid (MESH:D014535), MC1061 (-), glucuronic acid (MESH:D020723), HEPES (MESH:D006531), chondroitin (MESH:D002807), tetracycline (MESH:D013752), glycerol (MESH:D005990), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (MESH:C410687), GAGs (MESH:D006025), formate (MESH:C030544), heme (MESH:D006418), K2HPO4 (MESH:C013216), CTAB (MESH:D000077286), lactate (MESH:D019344), polysaccharides (MESH:D011134), N-acetylglucosamine (MESH:D000117), streptomycin (MESH:D013307), carbon (MESH:D002244), agar (MESH:D000362), heparosan (MESH:C560363)
- **Species:** Komagataella pastoris (species) [taxon 4922], Bos taurus (bovine, species) [taxon 9913], Streptococcus equi subsp. zooepidemicus (subspecies) [taxon 40041], Streptococcus sp. (species) [taxon 1306], Lactococcus lactis (species) [taxon 1358], Streptococcus pyogenes (species) [taxon 1314], Hepatovirus A (no rank) [taxon 12092], Streptococcus parauberis (species) [taxon 1348], Corynebacterium glutamicum (species) [taxon 1718], Bacillus subtilis (species) [taxon 1423], Escherichia coli (E. coli, species) [taxon 562], Streptococcus uberis (species) [taxon 1349], Escherichia coli Nissle 1917 (strain) [taxon 316435], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934015/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934015/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934015/full.md

---
Source: https://tomesphere.com/paper/PMC12934015